erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Khair OA et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. 1995 Eur. Respir. J. pmid:8575568
Kerr JR and Moore JE Potential for erythromycin resistance in porcine Campylobacter species. 1995 Trends Microbiol. pmid:8574518
Lynch HC and Bushell ME The physiology of erythromycin biosynthesis in cyclic fed batch culture. 1995 Microbiology (Reading, Engl.) pmid:8574403
Goswami BB et al. Physico-chemical properties and biological activities of erythromycin nalidixate. 1995 Arzneimittelforschung pmid:8573228
Roberts MC et al. Transferable erythromycin resistance in Listeria spp. isolated from food. 1996 Appl. Environ. Microbiol. pmid:8572704
Ishiura Y et al. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. 1995 Respir Med pmid:8570882
Tait A and Knowles JK Characterization of mitochondrial and cytoplasmic ribosomes from Paramecium aurelia. 1977 J. Cell Biol. pmid:856828
Christie CD et al. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. 1995 Infect Control Hosp Epidemiol pmid:8568199
Cherry JD Nosocomial pertussis in the nineties. 1995 Infect Control Hosp Epidemiol pmid:8568198
Leyh F [Syphilis therapy--results of an inquiry]. 1977 Hautarzt pmid:856770
Martins C et al. Allergic contact dermatitis from erythromycin. 1995 Contact Derm. pmid:8565504
Kelly DJ et al. Rickettsia tsutsugamushi infection in cell culture: antibiotic susceptibility determined by flow cytometry. 1995 Am. J. Trop. Med. Hyg. pmid:8561261
Arroyo J and Medoff G Mycobacterium chelonei infection: successful treatment based on a radiometric susceptibility test. 1977 Antimicrob. Agents Chemother. pmid:856032
Allen NE Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. 1977 Antimicrob. Agents Chemother. pmid:856018
Moriyama H et al. Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. 1995 Rhinology pmid:8560171
Mitsuyama T et al. Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase. 1995 Respiration pmid:8560094
Tauch A et al. The Corynebacterium xerosis composite transposon Tn5432 consists of two identical insertion sequences, designated IS1249, flanking the erythromycin resistance gene ermCX. 1995 Plasmid pmid:8559800
Tateishi T et al. Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test. 1995 Br J Clin Pharmacol pmid:8554946
Fujii T et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. 1995 Thorax pmid:8553295
Kawahara S et al. Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin. 1995 Drugs pmid:8549382
Fujimura M et al. Additive effect of continuous low dose ofloxacin on erythromycin therapy for sinobronchial syndrome. 1995 Drugs pmid:8549380
Saito A and Gaja M In vitro and in vivo activities of sparfloxacin in Legionella infections. 1995 Drugs pmid:8549320
Morrissey I and Smith JT Activity of new 4-quinolones in combination with erythromycin or tetracycline against S. pneumoniae. 1995 Drugs pmid:8549311
Bojar RA et al. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin. 1995 Drugs pmid:8549289
Stein CM et al. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine. 1996 Clin. Pharmacol. Ther. pmid:8549033
Brown GR Erythromycin-induced hypotension. 1995 Ann Pharmacother pmid:8547744
Ducloux D et al. [Pseudo-cholangitis, a form of erythromycin-induced hepatitis]. 1995 Presse Med pmid:8545387
Kenney DG et al. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia. 1994 Equine Vet. J. pmid:8542848
Tissi L et al. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. 1995 Antimicrob. Agents Chemother. pmid:8540695
Veber B and Pocidalo JJ [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia]. 1995 Pathol. Biol. pmid:8539075
Lagrange PH [Azithromycin, pharmacodynamic evaluation in animal models]. 1995 Pathol. Biol. pmid:8539074
Philippon A et al. [Azithromycin: critical points]. 1995 Pathol. Biol. pmid:8539070
Pechère JC [Effect of the molecular structure of azithromycin on pharmacokinetics and the antimicrobial activity]. 1995 Pathol. Biol. pmid:8539069
Littenberg B et al. A randomized controlled trial of oral albuterol in acute cough. 1996 J Fam Pract pmid:8537805
Hosie J et al. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis. 1995 J. Antimicrob. Chemother. pmid:8537264
Doucet-Populaire F et al. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. 1995 J. Antimicrob. Chemother. pmid:8537260
Shiba Y et al. Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs. 1996 Gastroenterology pmid:8536863
Hoppe JE and Tschirner T Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis. 1995 Eur. J. Clin. Microbiol. Infect. Dis. pmid:8536725
Izumikawa K et al. [The therapeutic effect of doxycycline (Vibramycin) on pneumonia due to mycoplasma pneumoniae (author's transl)]. 1977 Jpn J Antibiot pmid:853569
Benzamycin gel for acne. 1995 Drug Ther Bull pmid:8529541
Lestico MR and Smith AD Stevens-Johnson syndrome following erythromycin administration. 1995 Am J Health Syst Pharm pmid:8528839
Tee W et al. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. 1995 Clin. Infect. Dis. pmid:8527556
Kelentey BA and Kelentey BJ [Excretion of erythromycin, clindamycin and lincomycin into the saliva]. 1995 Fogorv Sz pmid:8522016
González Carro P et al. [Acute pancreatitis and erythromycin]. 1995 Rev Esp Enferm Dig pmid:8519548
Baird RM Antimicrobial drug use in hospitals. 1977 Can Med Assoc J pmid:851926
Suriñach JM et al. [Acute pancreatitis from erythromycin]. 1993 Rev Clin Esp pmid:8516513
Nakata M et al. Synthetic studies of erythromycin derivatives. Synthesis and antimicrobial activities of 3''-EPI-erythromycin A and (9S)-11-dehydroxy-9-deoxo-9-hydroxy-11- oxoerythromycin A. 1993 J. Antibiot. pmid:8514636
Kepczyk T et al. Effect of intravenous erythromycin on gastric emptying. 1993 May-Jun Gastrointest. Endosc. pmid:8514093
Narchi P et al. Interactions of pre-operative erythromycin administration with general anaesthesia. 1993 Can J Anaesth pmid:8513524
Suata K et al. Antimicrobial susceptibility patterns and resistance transferability among Bacteroides fragilis group isolates from patients with appendicitis in Bali, Indonesia. 1993 Clin. Infect. Dis. pmid:8513066